Day 4- April 2, 2004 Early Bird Breakfast Sessions 7:45AM-8:45AM
Early Bird 1: Values and Ethics in Decisions about Access to ARVs and Other Medicines Moderator: James Sabin, Steven Pearson
1.	The Values in Access to Medicine (VAMP) Project Steven Pearson, James Sabin
2.	Treating AIDS: Dilemmas of Unequal Access in Uganda Susan R Whyte Abstract Poster size=50.5 kb
Early Bird 2: Exploring Alternative Antibiotic Treatment Regimens: Methodology and Implications Moderator: Shamim Qazi, Jon Simon
1.	Introduction to the Global Collaboration to Explore Alternative Antibiotic Treatment Regimens Jonathon Simon
2.	Cost Study on Treating Severe Pneumonia in an Equivalence Trial of Oral Amoxicillin versus Injectable Penicillin in Children Aged 3 to 59 Months Archana Patel Abstract Poster size=995.5 kb
3.	3- Versus 5-Day Amoxicillin for Treatment of Non-Severe Pneumonia in Young Children: A Multi-Centre Randomized Trial Shally Awasthi Oral presentation Powerpoint size=109.5 kb Abstract Poster size=108.5 kb
4.	Efficacy of Short-Course Oral Amoxicillin Therapy for Non-Severe Pneumonia in Children Tabish Hazir Oral presentation Powerpoint size=89 kb Abstract Poster size=117.5 kb
5.	Three Days vs. Five Days Oral Cotrimoxazole Therapy in Non-Severe Pneumonia. Samir Saha Oral presentation Powerpoint size=311 kb Abstract Poster size=152 kb
Early Bird 3 Moderator: Jennifer J Furin, Hamish Fraser
1.	Video
Methodologycal Issues: Session 1 9:00AM-10:15AM
Methods 1: Methods for AMR Surveillance in Communities Moderator: Thomas Lund Sorensen, Visanu Thamlikitkul Rapporteur: Kurien Thomas
1.	Asian Network for Surveillance of Resistant Pathogens (ANSORP) : Envisioning the Future Against Infectious Diseases Visanu Thamlikitkul Oral presentation Powerpoint size=4779 kb Abstract
2.	Use of AMR Surveillance Data to Develop Infectious Diseases Standard Treatment Guidelines (STGs) in Developing Countries Anibal Sosa Oral presentation Powerpoint size=165 kb Abstract Poster size=78.5 kb
3.	Optimization of Antibiotic Therapy and Monitoring of Antibiotic Resistance in the Karaganda Region of Kazakhstan Denis Lobyntsev Oral presentation Powerpoint size=692.5 kb Abstract
4.	The Antimicrobial Resistance Surveillance Programme of Vietnam Do Khang Chien Oral presentation Powerpoint size=423.5 kb Abstract
Methods 2: Methods and Issues in Measuring Drug Prices to Improve Pricing Policies Moderator: Margaret Ewen Rapporteur: Kirsten Myhr
1.	Introduction to the Issue of Price Measurement and Overview of the Session Margaret Ewen Oral presentation Powerpoint size=531 kb
2.	Medicine Prices: A New Approach to Measurement Kirsten Myhr Oral presentation Powerpoint size=1700.5 kb
3.	The Rajasthan, India Experience Anita Kotwani Oral presentation Powerpoint size=837.5 kb
4.	Ensuring Data Quality in the Medicine Prices Project Jeanne Madden Oral presentation Powerpoint size=706 kb
5.	Collecting Retail Prices, Assessing Affordability General Discussion
Methods 3: Using Longitudinal Data for Evaluating Policy Changes and Other Interventions Moderator: Sauwakon Ratanawijitrasin, Stephen Soumerai Rapporteur: Anita Wagner
1.	Overview of the Session Anita Wagner, Sauwakon Ratanawijitrasin Oral presentation Powerpoint size=653.5 kb
2.	Using Hospital Information System, Dispensing, and Stock Record Data for Longitudinal Analyses: Lessons Learned Wimon Anansakunwatt Oral presentation Powerpoint size=1661 kb Abstract Poster size=1349 kb
3.	Routine Monitoring of Prescribing Patterns and Cost in the Philippines Health Insurance Corporation: A System Development Benjamin Palafox Oral presentation Powerpoint size=1626.5 kb Abstract
4.	The Information System of the Tamil Nadu Health Services Corporation: Opportunities and Challenges Ramachandran Murali Oral presentation Powerpoint size=3178.5 kb Abstract Poster size=139 kb
5.	Data Elements and Structures to Facilitate Longitudinal Analyses Daniel Gilden Oral presentation Powerpoint size=2890.5 kb
6.	Real-life Challenges in Developing Data Structures for Routine Reporting of Prescribing Data by Thai Hospitals Puree Anantachoti Oral presentation Powerpoint size=225.5 kb
7.	Improving the Quality of Longitudinal Data: Recommendations for Data Structures and System Development General Discussion
Methods 4: Methods for Assessing Adherence: Acute, Long-Term, and Chronic Illnesses Moderator: Susan Zimicki Rapporteur: Dennis Ross-Degnan
1.	Overview of Issues in Measuring Adherence to Therapy for Acute and Intermediate Term Infections Susan Zimicki Oral presentation Powerpoint size=531.5 kb
2.	Measuring Use of Antibiotics for Respiratory Illness in Household and Pharmacy Surveys Siritree Suttajit Oral presentation Powerpoint size=946 kb
3.	Understanding Factors that Improve Adherence to Anti-Malarial Therapy as an Essential Step in Developing Interventions to Improve Adherence Irene Akua Agyepong Oral presentation Powerpoint size=529.5 kb Abstract Poster size=276.5 kb
4.	High Adherence to Isoniazid for TB Preventive Therapy among HIV-Infected Persons in Chiang Rai, Thailand Jintana Ngamvithayapong-Yanai Oral presentation Powerpoint size=38 kb Abstract Poster size=2648 kb
Methods 5: Methods for Evaluating Training and Policy Interventions in Non-Experimental Settings Moderator: Anthony Smith, David Ofori-Adjei Rapporteur: Nick Freemantle
1.	Introduction to the Session and Overview of the Problem Anthony Smith Oral presentation Powerpoint size=13.5 kb
2.	Vaccine Storage and Administration among Primary Health Care Workers in South-East Nigeria: Effect of Educational Intervention Benjamin Uzochukwu Oral presentation Powerpoint size=617 kb Abstract Poster size=673.5 kb
3.	Evaluating International Drug and Therapeutics Committees Courses in the Developing World John Chalker Oral presentation Powerpoint size=1003.5 kb Abstract Poster size=540.5 kb
4.	An Evaluation of the WHO Rational Pharmacotherapy Teaching Program Suzanne Hill Oral presentation Powerpoint size=1014 kb Abstract Poster size=673 kb
5.	Methods for evaluating a Prescribing Curriculum for Australian Medical Students Anthony Smith Oral presentation Powerpoint size=612.5 kb Abstract Poster size=1079 kb
6.	A Multifaceted Continuing Medical Education Intervention Improves Primary Care Physicians’ Performance in Mexico Hortensia Reyes Oral presentation Powerpoint size=712 kb Abstract Poster size=129.5 kb
Methods 6: Measuring Effectiveness and Appropriate Use of Complementary/Alternative Medicines Moderator: Torkel Falkenberg, Ranjit Roy Chaudhury Rapporteur: Sallie Anne Pearson
1.	Introduction to the Expansive Area of TCAM from an International Health Systems Research and Development Perspective Torkel Falkenberg Oral presentation Powerpoint size=1436.5 kb
2.	Prescription Patterns for Treatment of Haemorrhoids Before and After Implementation of the Universal Coverage Policy: A Study in a Community Hospital, Chiang Mai Province, Thailand Orapin Chaipayom Oral presentation Powerpoint size=1593 kb Abstract Poster size=127 kb
3.	Our Experiences with Natural Products as Potential Therapeutic Agents: Towards Safer and Cost-Effective Therapy Chanda Kulkarni Oral presentation Powerpoint size=48453.5 kb Abstract Poster size=73 kb
4.	Pharmacists’ Perceptions of the Development of the Herbal Medicines Market in Iran Gholamreza Asghari Oral presentation Powerpoint size=421.5 kb Abstract Poster size=572 kb
5.	Pharmacoepidemiology of Herbal Drugs in Addis Ababa and Butajira, Centeral Ethiopia Teferi Gedif Fenta Oral presentation Powerpoint size=1210.5 kb Abstract Poster size=1210.5 kb
6.	Adverse Events Associated with Turmeric Preparations: Consumer Reporting Experience Wimon Suwankesawong Oral presentation Powerpoint size=1204.5 kb Abstract Poster size=618.5 kb
Methods 7: Methods for Selecting Medicines on Essential Medicines Lists Moderator: Richard Laing, Brenda Waning Rapporteur: Klara Tisocki
1.	Evaluation of Type C Hospital Formularies in Yogyakarta (Abstract AC002) Yusi Anggriani Oral presentation Powerpoint size=1012.5 kb Abstract Poster size=117.5 kb
2.	A Pilot Study Examining Criteria Used to Select Drugs for Hospital, Provincial and National Formularies Jane Robertson Oral presentation Powerpoint size=1189 kb Abstract Poster size=265 kb
3.	Discrepancies between International and National Lists of Essential Reproductive Health Medicines Shalini Jayasekar Oral presentation Powerpoint size=716 kb Abstract Poster size=302.5 kb
4.	Developing National Formularies Based on the WHO Model Formulary (Abstract AC084) Klara Tisocki Oral presentation Powerpoint size=771 kb Abstract Poster size=89 kb
5.	Comparative Analysis of Essential Drugs Lists in Four Central Asian Republics (Kazakhstan, Kyrgyzstan, Tajikistan, and Uzbekistan) Aziz Jafarov Oral presentation Powerpoint size=174.5 kb Abstract Poster size=80.5 kb
6.	Scoring System for the Development of the National List of Essential Drugs (NLED) in Thailand Pisonthi Chongtrakul Oral presentation Powerpoint size=1211 kb Abstract Poster size=622 kb
7.	Assessment of the Selection Process for the 2003 National List of Essential Drugs (NLED) of Thailand Worasuda Yoongthong Oral presentation Powerpoint size=107 kb Abstract Poster size=122 kb
Methodological Issues: Session 2 11:10AM-12:40PM
Methods 1: Methods for AMR Surveillance in Communities (Continuation) Moderator: Kathleen Holloway, Kurien Thomas Rapporteur: Thomas Lund Sorensen
1.	WHO Pilot Projects to Contain Antimicrobial Resistance Kathleen Holloway Oral presentation Powerpoint size=287.5 kb Abstract Poster size=287.5 kb
2.	Challenges in Setting up a District-Based Antimicrobial Use Surveillance Program Andries GS Gous Oral presentation Powerpoint size=638.5 kb Abstract Poster size=52.5 kb
3.	Antimicrobial Use and Resistance Surveillance Pilot Project: Lessons from the Durban Site Andy Gray Oral presentation Powerpoint size=11349.5 kb Abstract Poster size=838.5 kb
4.	Surveillance of Antimicrobial Resistance and Use in the Community: A Time-Series Study. Urmila Thatte Oral presentation Powerpoint size=1019 kb Abstract
5.	Antimicrobial Use and Resistance of E. Coli in Pregnant Women in India Sujith Chandy Oral presentation Powerpoint size=372 kb Abstract Poster size=107 kb
Methods 2: Methods and Issues in Measuring Drug Prices to Improve Pricing Policies (Continuation) Moderator: Margaret Ewen Rapporteur: Kirsten Myhr
1.	Cost as a Barrier to Access: Identifying the Component Costs of Essential Medicines Libby Levison Oral presentation Powerpoint size=1146.5 kb Abstract
2.	The Influence of Value Added Tax (VAT) Elimination on Drug Access Saliya Karymbaeva Oral presentation Powerpoint size=631.5 kb Abstract Poster size=151 kb
3.	Comparing Medicine Prices among Countries: Methods and Issues Jeanne Madden Oral presentation Powerpoint size=925.5 kb
4.	WHO-HAI Pricing Project Website: An International Resource for Pharmaceutical Price Measurement Margaret Ewen
Methods 3: Using Longitudinal Data for Evaluating Policy Changes and Other Interventions (Continuation) Moderator: Stephen Soumerai, Sauwakon Ratanawijitrasin Rapporteur: Anita Wagner
1.	Analyzing the Effect of Cost Sharing on Availability of Drugs and Utilization of Services in Public Health Facilities in Uganda Winifred Adrine Tumwikirize Oral presentation Powerpoint size=221 kb Abstract Poster size=241 kb
2.	A Generalized Linear Model for Estimation of Drug Expenditures Supon Limwattananon Oral presentation Powerpoint size=124.5 kb
3.	Segmented Regression Analyses of Longitudinal Data Anita Wagner Oral presentation Powerpoint size=950.5 kb
4.	Challenging Methodological Issues and Recommendations for Improving the State of the Art in Longitudinal Policy Evaluation General Discussion
Methods 4: Methods for Assessing Adherence: Acute, Long-Term, and Chronic Illnesses (Continuation) Moderator: Susan Zimicki Rapporteur: Dennis Ross-Degnan
1.	Overview of Issues in Measuring Adherence to Therapy for Chronic Illness Using Claims Databases and Other Methods Dennis Ross-Degnan Oral presentation Powerpoint size=755.5 kb
2.	Do Fixed-Dose Pills or Unit-of-Use Packaging Improve Adherence? A Systematic Review Jennie Connor Oral presentation Powerpoint size=658 kb Abstract Poster size=71.5 kb
3.	Baseline Data and Predictors of Adherence in Patients on Antiretroviral Therapy in Maun General Hospital [MGH], Maun, Botswana. Jude Nwokike Oral presentation Powerpoint size=1367.5 kb Abstract Poster size=84 kb
4.	Recommendations for Improving Measurement of Adherence and Future Research Issues General Discussion
Methods 5: Methods for Evaluating Training and Policy Interventions in Non-Experimental Settings (Continuation) Moderator: Anthony Smith, David Ofori-Adjei Rapporteur: Nick Freemantle
1.	An Intervention to Improve Antibiotic Prescribing Habits of Doctors in a Teaching Hospital Francis Ofei Oral presentation Powerpoint size=602 kb Abstract
2.	Cambodia Experience: Monitoring-Training-Planning (MTP) to Reduce Inappropriate Medicine Use in Hospitals Chroeng Sokhan Oral presentation Powerpoint size=1469 kb Abstract Poster size=1043.5 kb
3.	Educational Intervention to Improve Prescribing Habits of Pediatricians in Treatment of Uncomplicated Acute Upper Respiratory Tract Infection Lilia Ziganshina Oral presentation Powerpoint size=677.5 kb Abstract Poster size=923.5 kb
4.	Methodological Issues in Quality Improvement Studies Marissa Alejandria Oral presentation Powerpoint size=795 kb Abstract Poster size=38 kb
5.	Quasi-Experimental Study Designs in Evaluating Medicine Use Interventions Lloyd Matowe Oral presentation Powerpoint size=686 kb Abstract Poster size=66.5 kb
6.	Summary of Best Practices and Recommendations for Future Research General Discussion
Methods 6: Measuring Effectiveness and Appropriate Use of Complementary/Alternative Medicines (Continuation) Moderator: Torkel Falkenberg, Jasper Ogwal-Okeng Rapporteur: Sallie Anne Pearson
1.	Increasing Herbal Product Consumption in Thailand During the Period 2001-2003 Arthorn Riewpaiboon Oral presentation Powerpoint size=403 kb Abstract Poster size=211.5 kb
2.	Problems in Clinical Trials with Alternative Medicine Urmilla Thatte, Ranjit Roy Chaudhury Oral presentation Powerpoint size=1336.5 kb
3.	Highlighting Challenging Methodological Issues General Discussion
4.	Future Research Agenda, Summary, and Recommendations General Discussion
Methods 7: Methods for Selecting Medicines on Essential Medicines Lists (Continuation) Moderator: Richard Laing, Brenda Waning Rapporteur: Klara Tisocki
1.	Best Practice in Selecting Medicines and Areas of Future Research General Discussion
Presentation and Revision of Topic Track Summaries 1:50PM-3:05PM
Access: Review of Summary Points from Access Track Moderator: Richard Laing, Sauwakon Ratanawijitrasin
1.	Presentation and Revision of Track Summary Findings and Recommendations Track rapporteur Oral presentation Powerpoint size=366.5 kb
Adult: Review of Summary Points from Adult Health Track Moderator: Ricardo Perez-Cuevas
1.	Presentation and Revision of Track Summary Findings and Recommendations Track rapporteur Oral presentation Powerpoint size=86.5 kb
AMR: Review of Summary Points from AMR Track Moderator: Kathleen Holloway, Visanu Thamlikitkul
1.	Presentation and Revision of Track Summary Findings and Recommendations Track rapporteur Oral presentation Powerpoint size=56 kb
Child: Review of Summary Points from Child Health Track Moderator: Jonathon Simon
1.	Presentation and Revision of Track Summary Findings and Recommendations Track rapporteur Oral presentation Powerpoint size=932 kb
HIV: Review of Summary Points from HIV Track Moderator: Davidson Hamer
1.	Presentation and Revision of Track Summary Findings and Recommendations Track rapporteur Oral presentation Powerpoint size=615 kb
Malaria: Review of Summary Points from Malaria Track Moderator: Susan Zimicki
1.	Presentation and Revision of Track Summary Findings and Recommendations Track rapporteur Oral presentation Powerpoint size=527 kb
TB: Review of Summary Points from TB Track Moderator: Akihiro Seita
1.	Presentation and Revision of Track Summary Findings and Recommendations Track rapporteur Oral presentation Powerpoint size=36.5 kb
Presentation of Conference Summaries and Closing 3:30PM-5:30PM
2.	Summary Track coordinators Video (wmv)
Presentation of Topic Track and Conference Summaries
1.	Summary of Key Conference Findings and Recommendations Hans V Hogerzeil, Acting Director WHO Essential Drugs and Medicines Policy Video (wmv) Video (realvideo)
2.	Increasing Global Access to Medicines and Encouraging Appropriate Use: What Lies Ahead? Suwit Wibulpolprasert, Deputy Permanent Secretary, Thailand Ministry of Public Health and Board of Directors, The Global Fund Oral presentation Powerpoint size=160 kb Video (wmv) Video (realvideo)